Furthermore, beside its potential beneficial effects, the thrombogenic effect of this erythropoiesis-stimulating hormone was critically discussed in the context of clinical studies (18, 19), as tissue-protective effects require high levels of EPO and administration of high EPO doses can increase the risk of thrombosis (16) and hypertension (17). This evidence concerns the gene EPO and hypertensive disorder.